Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patients
Submitted: April 25, 2024
Accepted: September 17, 2024
Published: October 24, 2024
Accepted: September 17, 2024
Abstract Views: 323
PDF_EARLY VIEW: 71
SUPPLEMENTARY MATERIAL: 8
SUPPLEMENTARY MATERIAL: 8
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Cleante Scarduelli, Francesco Inglese, Massimiliano Beccaria, Fabio Spreafico, Martina Garuti, Antonietta Pecoriello, Giulia Cervi, Graziana Greco, Sara Scarduelli, Giuseppe Lucchini, Giuseppe De Donno, Claudio Borghi, Pulmonary embolism in patients with severe COVID-19 treated with intermediate- to full-dose enoxaparin: A retrospective study , Monaldi Archives for Chest Disease: Vol. 91 No. 3 (2021)
- Roberto Valle, Nadia Aspromonte, Emanuele Carbonieri, Giorgio De Michele, Giuseppe Di Tano, Prospero Giovinazzo, Roberta Cioè, Tiziana Di Giacomo, Loredano Milani, Federica Noventa, Mario Chiatto, BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure , Monaldi Archives for Chest Disease: Vol. 68 No. 3 (2007): Cardiac series
- Paolo Biagi, Luigi Abate, Massimo Alessandri, Salvatore Bocchini, Valerio Verdiani, Giuseppe Pettinà , Carlo Nozzoli, Heart failure with preserved systolic function: prevalence and clinical features in a cohort of patients admitted to internal medicine units. The study PRESYF-HF Tuscany , Monaldi Archives for Chest Disease: Vol. 68 No. 3 (2007): Cardiac series
- J.P. Heinzmann-Filho, P.J.C. Marostica, M.V.F. Donadio, Ventilatory muscle strength in cystic fibrosis patients: a literature review , Monaldi Archives for Chest Disease: Vol. 77 No. 3-4 (2012): Pulmonary series
- Ugo Corrà , Massimo F. Piepoli, Summary Statement on Cardiopulmonary Exercise Testing in Chronic Heart Failure due to Left Ventricular Dysfunction Recommendations for Performance and Interpretation , Monaldi Archives for Chest Disease: Vol. 68 No. 1 (2007): Cardiac series
- A. Andreani, G. Cappiello, M. Valli, M. Giovannini, TBNA for the treatment of non complicated bronchogenic cyst , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series
- Gabriella Malfatto, Paola Cuoccio, Caterina Bizzi, Giovanna Branzi, Alessandra Villani, Francesco Della Rosa, Gianfranco Parati, Mario Facchini, What underlies NYHA class in elderly patients with heart failure? role of diastolic dysfunction, functional mitral regurgitation and abnormal ventilation during exercise , Monaldi Archives for Chest Disease: Vol. 72 No. 2 (2009): Cardiac series
- Paolo Biagi, Luigi Abate, Heart failure, oxidative stress and allopurinol , Monaldi Archives for Chest Disease: Vol. 64 No. 1 (2005): Cardiac series
- L. Casali, G. Pinchi, E. Puxeddu, Doping and Respiratory System , Monaldi Archives for Chest Disease: Vol. 67 No. 1 (2007): Pulmonary series
- Marzia Testa, Enrico Lombardo, Enrico Avogadri, Marco Agostini, Giuseppe Forte, Salvatore Piccolo, Mauro Feola, Infective endocarditis or myxoma? Description of a patient with new diagnosis of congestive heart failure , Monaldi Archives for Chest Disease: Vol. 78 No. 2 (2012): Cardiac series
<< < 3 4 5 6 7 8 9 10 11 12 > >>
You may also start an advanced similarity search for this article.